Home › Research › Health systems and care delivery
Lawsuit Challenges Medicare Part D Transition Plan For Dual Eligibles
Mark F. Moran. Psychiatric News, 2005-12-16
Topic: Risk, prevention and care in population studies
But advocacy groups, including APA, have been bracing for enormous complications with transitioning these beneficiaries— some 2 million of whom are believed to have mental illness—into the new program.The lawsuit, filed against Health and Human Services (HHS) Secretary Mike Leavitt, alleges that the federal government is failing to ensure that transfer, with potentially catastrophic results.Leavitt "is not taking adequate steps to meet his obligations under the statute," the lawsuit alleges. "Unless he does so, countless dual eligibles will fall through the cracks of this massive program transition; they will not be effectively transferred to new Medicare prescription drug coverage and may be left without needed prescription drug coverage on and after January 1, 2006.
Key findings
- But advocacy groups, including APA, have been bracing for enormous complications with transitioning these beneficiaries— some 2 million of whom are believed to have mental illness—into the new program.The lawsuit, filed against Health and Human Services (HHS) Secretary Mike Leavitt, alleges that the federal government is failing to ensure that transfer, with potentially catastrophic results.Leavitt "is not taking adequate steps to meet his obligations under the statute," the lawsuit alleges. "Unless he does so, countless dual eligibles will fall through the cracks of this massive program transition; they will not be effectively transferred to new Medicare prescription drug coverage and may be left without needed prescription drug coverage on and after January 1, 2006.
Why it matters
This is a lawsuit alleging that the federal government is not taking adequate steps to transfer dual-eligible beneficiaries to Medicare Part D prescription drug coverage. It warns that without adequate steps, many dual eligibles may be left without needed prescription drug coverage.
Study details
- Evidence strengthLow
How this study scored 22/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on institution's track record, so that was left out: it earned 21 of the 97 points we could judge it on, which is 22 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Psychiatric News) |
| Journal's citation record | 0 / 4 | Psychiatric News: journal h-index 17 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2005 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 23 year(s) since 2005 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Mark Moran: h-index 15 (OpenAlex, whole career) |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multi-centre collaboration | 0 / 3 | OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 21 / 97 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 21 of the 97 points we could judge it on is 22 out of 100. |
| Total | 22 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
APA 7th
Moran, M. F. (2005). Lawsuit Challenges Medicare Part D Transition Plan For Dual Eligibles. Psychiatric News. https://doi.org/10.1176/pn.40.24.0001a
Vancouver
Moran MF. Lawsuit Challenges Medicare Part D Transition Plan For Dual Eligibles. Psychiatric News. 2005. doi:10.1176/pn.40.24.0001a.
BibTeX
@article{moran2005-70f7e086,
author = {Moran, Mark F.},
title = {{Lawsuit Challenges Medicare Part D Transition Plan For Dual Eligibles}},
journal = {Psychiatric News},
year = {2005},
doi = {10.1176/pn.40.24.0001a},
url = {https://doi.org/10.1176/pn.40.24.0001a}
}
Related studies in Health systems and care delivery
Also in Health systems and care delivery
172 studies in the library are filed under Health systems and care delivery with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Health systems and care delivery hub.